Type of Assessment:
Risk Assessment, Registration Review
Title:
Open For Comments:
Sep 2, 2020, 12:00 AM
Comments Due:
Nov 2, 2020, 12:00 AM
Summary:
This notice announces the availability of EPA's draft human health and/or ecological risk assessments for the registration review of 10,10'-oxybisphenoxarsine (OBPA), amicarbazone, aminopyralid, dimethenamid/dimethenamid-p, endothall, fluoxastrobin, folpet, ipconazole, iprodione, metconazole, polixetonium chloride, prothioconazole, sodium pyrithione.